Showing results (221-230 of 483) with videos related to
Sort By:
Pageof 49
Prostaglandins, Leukotrienes, and Medicine|June 1, 1986
Biological half-life of prostacyclin and 6-oxo-PGF1 alpha levels in plasma of patients with colonic cancerP Polterauer, H Sinzinger, B A PeskarProstaglandins and Medicine|July 1, 1981
Increased plasma levels of 6-oxo-prostaglandin F1 alpha, a stable metabolite of prostacyclin, in acute kidney transplant rejectionC Leithner, H Sinzinger, B A PeskarThe American Journal of Cardiology|March 1, 1986
Bicyclo-prostaglandin E2 metabolite in congestive heart failure and relation to vasoconstrictor neurohumoral principlesC Punzengruber, B Stanek, H Sinzinger, et al.Experientia|March 15, 1980
Is the variation in the susceptibility of various species to atherosclerosis due to inborn differences in prostacyclin (PGI2) formationH Sinzinger, P Clopath, K Silberbauer, et al.Progress in Clinical and Biological Research|January 1, 1990
Platelet scintigraphy and survival in juvenile stroke patientsB Pramsohler, G Lupattelli, H Scholz, et al.Acta Anatomica|January 1, 1979
Alterations of the internal elastic membrane in juvenile human arteriesM Winter, M Helletzgruber, R Oppolzer, et al.Wiener Klinische Wochenschrift|February 3, 1984
[In vitro and in vivo studies using 111 indium oxine, 111 indium oxine sulfate and 99m Tc oxine in erythrocyte labeling]S Reiter, P Angelberger, H Kolbe, et al.Artery|January 1, 1980
Effect of experimentally induced diabetes on swine vascular prostacyclin (PGI2) synthesisK Silberbauer, P Clopath, H Sinzinger, et al.Lancet (London, England)|February 18, 1984
Parathyroid hormone does not inhibit platelet aggregationC Leithner, J Kovarik, H Sinzinger, et al.Prostaglandins|January 1, 1991
Enhanced mitotic activity induced by irradiation is abolished by PGI2 pretreatmentH Sinzinger, T Zidek, F Rauscha, et al.Pageof 49